Delivery Order SPE2DR25D3101-SPE2DR26F5V16
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Vivitrol 380 mg vials and diluents, with a ceiling value of $7,385.49. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The contract calls for delivery to the company's headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,947.01 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of December 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the established pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for Vivitrol 380 mg vial-diluents with a ceiling value of $1,055.07. This is a firm fixed price delivery order with an ultimate completion date of December 10, 2025, and represents a non-competitive award under an existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,055.07 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of November 28, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a competitive award to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,055.07 for VIVITROL 380 mg vials with diluents on December 2, 2025, with a completion date of December 3, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $6,330.42 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This non-competitive delivery order, issued on November 24, 2025, represents a firm fixed-price transaction with an ultimate completion date of November 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $23,303.74 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials and diluents, with an ultimate completion date of December 22, 2025. This competitively awarded, firm fixed-price delivery order was issued on December 19, 2025, with no set-aside designation. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $45,056.28 delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Vivitrol 380 mg vial-diluents. The contract represents a firm fixed-price delivery order with an ultimate completion date of October 31, 2025, and was awarded competitively without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor...
- The Defense Logistics Agency awarded a delivery order valued at $1,839.49 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vials with diluents, with a firm fixed price and an ultimate completion date of June 3, 2025. This non-set-aside competitive award was placed with AmerisourceBergen's Corporate Office located in Conshohocken, Pennsylvania, the company's headquarters. The delivery order represents a child contract under a larger vehicle supporting federal pharmaceutical procurement. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,357.27 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of September 17, 2025. This is a firm fixed price contract with no set-aside designation, reflecting competitive procurement practices. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is executed under...
- SPE2DR25D3101Indefinite Delivery Contract
- SPE2DR25D3101-SPE2DR26F5V16Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,055.07 for Vivitrol 380 mg vial-diluents under a firm fixed price contract. The award, issued on December 29, 2025, represents a non-competitive, non-set-aside delivery order with an ultimate completion date of December 30, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, has demonstrated consistent capability to fulfill federal requirements through open competition across a diverse portfolio of therapeutic domains, positioning it as a key provider for Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/28/25 |